“The Selling of Attention Deficit Disorder” The New York Times December 15, 2013
The New York Times article “The Selling of Attention Deficit Disorder” published December 15, 2013 had quoted me towards the end of article. As I had previously written in my blog posting, the quote was taken out of ... Read More
Tag: David W. Goodman MD
09
Dec2013
Weisler R, Adler LA, Kollins SH, Goodman DW, Hamdani M, Dirks B, Childress AC. Neuropsychiatric Disease and Treatment 2014:9 1–11.
Abstract
BACKGROUND:
Attention-deficit/hyperactivity disorder (ADHD) symptom presentation across age and sex has not been fully elucidated. The present post hoc analyses qualitatively explored the baseline levels of ADHD symptomatology across subgroups in two ... Read More
December 9, 2013Jourdan Hathaway
18
Oct2013
I am very honored to be an invited faculty speaker at the annual Neuroscience Education Institute Psychopharmacology Congress in Colorado in November 2013. This is a large gathering of psychiatrists, primary care physicians, nurse practitioners, psychologists, clinical social workers, and others who are interested in upgrading their understanding of the use of ... Read More
October 18, 2013David W. Goodman, MD
26
Sep2013
In the September issue 2013 of Attention Magazine, published by the national organization CHADD (Children and Adults with ADHD), my article was published on ADHD in people age 50 and older. There is remarkably little research looking at this population of patients. Clinical medication trials that seek the FDA approval for the ... Read More
September 26, 2013David W. Goodman, MD
13
Sep2013
All ADHD medications that are FDA approved to treat adults have designated maximum daily doses. It is important to understand how these daily maximum doses are determined in order to consider higher doses beyond these thresholds. The FDA receives the clinical registration trial research and it makes a determination of ... Read More
September 13, 2013David W. Goodman, MD
28
Aug2013
Style magazine in Baltimore has published an article in September 2012 edition on stimulant misuse in high school students in Baltimore. The article distinguishes between the use of stimulants for performance enhancement by students vs the use of stimulants to treat legitimately diagnosed ADHD in young adults. I, along with Dr. ... Read More
August 28, 2013David W. Goodman, MD
10
Aug2013
Goodman DW, Surman C et al. Medscape. August 2013
Overview
This activity is intended for psychiatrists, family physicians, primary care providers, internists, neurologists.
The goal of this activity is to apprise clinicians of the symptoms of adult attention-deficit/hyperactivity disorder (ADHD), the comorbidities commonly associated with the disorder, and the pharmacotherapy and nonpharmacotherapy treatment ... Read More
August 10, 2013Jourdan Hathaway
03
Aug2013
American Professional Society for ADHD and Related Disorders (APSARD) is an organization founded by a national and international group of experts in ADHD treatment and research. The annual meeting, “ADHD Advances: Challenges and Opportunities” being held September 27 – 28, 2013 at the Hyatt Regency Washington on Capitol Hill in ... Read More
August 3, 2013David W. Goodman, MD
02
Aug2013
Don’t miss this extra-ordinary conference on ADHD. CHADD has an annual conference open to patients and family, the general public, and professionals. The conference is held in a different location around the country. This year it is in our backyard in Washington, DC.
I’m honored to be invited to present a 3 hour ... Read More
August 2, 2013David W. Goodman, MD
23
May2013
Goodman DW. Editorial on Sonuyga-Barke for EBMH. Evidence-Based Mental Health, Brit Med J. May 2013.
Question: Are dietary and pharmacological interventions effective for the treatment of attention deficit hyperactivity disorder (ADHD)?
Outcomes: Post-treatment change from baseline in total ADHD symptom severity as measured by ADHD-specific symptom scales (eg, the Diagnostic and Statistical ... Read More
May 23, 2013Jourdan Hathaway